L-Penicillamine Tartrate CAS 500003-68-9

Product Name:L-Penicillamine tartrate
CAS NO.:500003-68-9
Appearance:White powder
TNN specializes in food additives, pharmaceutical ingredients, Cosmetic Raw Materials, Fine Chemicals, etc. Please feel free to inquire if you have any needs.

Send Inquiry

Description

The TNN Development Limited is one of the most reliable manufacturers and suppliers of l-penicillamine tartrate cas 500003-68-9 in China. Please feel free to wholesale customized l-penicillamine tartrate cas 500003-68-9 at low price from our factory. If you have any enquiry about free sample and discount information, please feel free to email us.

Products Description

Product name	D,L-Pen-OH
CAS NO.	500003-68-9
Purity	＞95%
Alcohol	without alcohol
Packaging Type	PP bag /cardboard bucket
Material	pharmaceutical intermediates
Sheet Size	1kg/10kg/20kg
Prodcut Weight	1.2kg/12kg/23kg
Counts	1kg/bag 10kg/bucket 20kg/bucket
Certifications	ISO9001
Shelf life	24 month
MOQ	100 g

Functions

L-Penicilline tartrate (CAS: 500003-68-9) is a high-value pharmaceutical intermediate optimized for performance through salt formation technology. This compound combines the active structure of L-penicillamine with the stable properties of tartaric acid, which not only enhances the crystallinity and process operability of the raw materials, but also demonstrates unique value as a key chiral synthetic block in innovative drug synthesis.
In the field of drug development, this salt form intermediate plays a strategic role in constructing complex bioactive molecules. It is an important chiral building block for Johnson&Johnson's development of oral IL-23 receptor cyclic peptide inhibitors, and its stable physicochemical properties ensure the reliability of complex cyclic peptide synthesis processes. More importantly, as a key chiral precursor for the synthesis of HIV-1 protease inhibitors (such as JE-2147 in clinical stage), it provides an indispensable molecular skeleton for the development of highly effective anti AIDS drugs. In addition, its derivative applications have also extended to the research and development of cutting-edge fields such as cardiovascular therapy drug SD-3321 and anti-cancer drug AG-3340, demonstrating broad market potential.
As an important intermediate for the synthesis of antimicrobial active ingredients (APIs), the successful development of L-penicillamine tartrate reflects the trend of refinement in drug synthesis chemistry. By forming a stable salt form, not only did it solve the technical difficulties in the process, but it also laid a solid foundation for the subsequent synthesis of high-purity and highly active targeted drugs, occupying an important position in the modern pharmaceutical research and development industry chain.